Related Experiment Video
Updated: Jun 22, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
JFK, a Kelch domain-containing F-box protein, links the SCF complex to p53 regulation
Luyang Sun1, Lei Shi, Wenqian Li
1Department of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing, China.
Abstract:
The p53 tumor suppressor plays a central role in integrating cellular responses to various stresses. Tight regulation of p53 is thus essential for the maintenance of genome integrity and normal cell proliferation. Currently, several ubiquitin ligases, including the single-subunit RING-finger types--MDM2, Pirh2, and COP1--and the HECT-domain type--ARF-BP1--have been reported to target p53 for degradation. Here, we report the identification of a human Kelch domain-containing F-box protein, JFK. We showed that JFK promotes ubiquitination and degradation of p53. But unlike MDM2, Pirh2, COP1, and ARF-BP1, all of which possess an intrinsic ubiquitin ligase activity, JFK destabilizes p53 through the assembly of a Skp1-Cul1-F-box complex. Significantly, JFK inhibits p53-dependent transcription, and depletion of JFK stabilizes p53, promotes cell apoptosis, arrests cells in the G(1) phase, and sensitizes cells to ionizing radiation-induced cell death. These data indicate that JFK is a critical negative regulator of p53 and represents a pathway for the maintenance of p53 levels in unstressed cells. Our experiments link the Skp1-Cul1-F-box system to p53 regulation.
Insights
JFK, a novel F-box protein, targets the p53 tumor suppressor for degradation via the Skp1-Cul1-F-box complex. Depleting JFK stabilizes p53, promoting apoptosis and sensitizing cells to radiation.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The p53 tumor suppressor is crucial for maintaining genome integrity and regulating cell proliferation in response to cellular stress.
- Several ubiquitin ligases, including MDM2, Pirh2, COP1, and ARF-BP1, are known to degrade p53.
- Understanding p53 regulation is vital for cancer therapy.
Purpose of the Study:
- To identify novel regulators of p53.
- To investigate the role of the F-box protein JFK in p53 regulation.
- To elucidate the mechanism by which JFK affects p53 stability and function.
Main Methods:
- Identification and characterization of the F-box protein JFK.
- Assays to determine JFK's effect on p53 ubiquitination and degradation.
- Analysis of JFK's role in p53-dependent transcription and cellular processes.
- Depletion studies using siRNA to assess the in vivo function of JFK.
Main Results:
- JFK, a human Kelch domain-containing F-box protein, was identified.
- JFK promotes the ubiquitination and degradation of p53.
- Unlike other ligases, JFK functions through the Skp1-Cul1-F-box complex to destabilize p53.
- JFK depletion leads to p53 stabilization, G1 cell cycle arrest, apoptosis, and increased sensitivity to ionizing radiation.
Conclusions:
- JFK is a critical negative regulator of p53.
- JFK contributes to maintaining low p53 levels in unstressed cells.
- This study links the Skp1-Cul1-F-box system to the regulation of p53, offering new insights into cancer biology.
Related Concept Videos
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity

